Product NDC: | 58394-001 |
Proprietary Name: | BeneFIX |
Non Proprietary Name: | coagulation factor ix (recombinant) |
Active Ingredient(s): | & nbsp; coagulation factor ix (recombinant) |
Administration Route(s): | |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58394-001 |
Labeler Name: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA103677 |
Marketing Category: | BLA |
Start Marketing Date: | 19970201 |
Package NDC: | 58394-001-06 |
Package Description: | 1 KIT in 1 CARTON (58394-001-06) * 5 mL in 1 SYRINGE (58394-020-01) * 1 SWAB in 1 PACKET * 5 mL in 1 VIAL, SINGLE-USE (58394-101-06) |
NDC Code | 58394-001-06 |
Proprietary Name | BeneFIX |
Package Description | 1 KIT in 1 CARTON (58394-001-06) * 5 mL in 1 SYRINGE (58394-020-01) * 1 SWAB in 1 PACKET * 5 mL in 1 VIAL, SINGLE-USE (58394-101-06) |
Product NDC | 58394-001 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | coagulation factor ix (recombinant) |
Dosage Form Name | KIT |
Route Name | |
Start Marketing Date | 19970201 |
Marketing Category Name | BLA |
Labeler Name | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |